CLIOSS

CLIOSS is a full-service Clinical Research Organization (CRO) specializing in oncology, operating as a subsidiary of the NMS Group (Nerviano Medical Sciences). Based in Italy, the company provides comprehensive clinical development services, including trial design, regulatory affairs, clinical monitoring, and data management. CLIOSS is primarily responsible for advancing the NMS Group's internal pipeline of novel cancer therapeutics from Phase 1 through Phase 3, while also offering its expertise to external pharmaceutical and biotech partners. The company leverages its deep integration within the NMS oncology hub to streamline the transition from preclinical research to clinical proof-of-concept. Its expertise covers a wide range of therapeutic modalities, with a strong historical focus on small molecule inhibitors targeting cell cycle and signaling pathways.